RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Marlene Camacho-Rivera to Antineoplastic Agents

Back to Details
This is a "connection" page, showing publications Marlene Camacho-Rivera has written about Antineoplastic Agents.
Marlene Camacho-Rivera
Connection Strength
0.140
Antineoplastic Agents
  1. Islam JY, Hathaway CA, Hume E, Turner K, Hallanger-Johnson J, Tworoger SS, Camacho-Rivera M. Characteristics of Patients With Cancer and COVID-19 Who Discontinued Cancer Treatment. JAMA Netw Open. 2024 May 01; 7(5):e2411859.
    View in: PubMed
    Score: 0.140
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support